U.S. Markets open in 6 hrs 36 mins

Verastem, Inc. (VSTM)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
2.48+0.13 (+5.53%)
At close: 4:00PM EDT
People also watch
Interactive chart
Previous Close2.35
Bid1.61 x 2000
Ask2.55 x 600
Day's Range2.43 - 2.50
52 Week Range1.05 - 2.54
Avg. Volume511,682
Market Cap91.74M
PE Ratio (TTM)-2.23
EPS (TTM)-1.11
Earnings DateAug 7, 2017 - Aug 11, 2017
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est4.38
Trade prices are not sourced from all markets
  • Business Wire5 days ago

    Verastem Announces Duvelisib Data Presentations at the 22nd Congress of the European Hematology Association

    Verastem, Inc. , focused on discovering and developing drugs to improve the survival and quality of life of cancer patients, today announced an abstract featuring long-term follow up data from the DYNAMO® study evaluating duvelisib in patients with follicular lymphoma has been selected for oral presentation at the 22nd Congress of the European Hematology Association being held June 22-25, 2017 in Madrid, ...

  • Accesswire12 days ago

    Today's Research Reports on Stocks to Watch: Array Biopharma and Verastem

    NEW YORK, NY / ACCESSWIRE / May 11, 2017 / U.S. markets were relatively quiet Wednesday as investors analyzed the latest batch of corporate earnings. Additionally, President Trump on Wednesday announced ...

  • Associated Press12 days ago

    Verastem reports 1Q loss

    The Needham, Massachusetts-based company said it had a loss of 35 cents per share. Losses, adjusted for stock option expense, came to 32 cents per share. The results surpassed Wall Street expectations. ...